MX365656B - Nuevas vacunas contra multiples subtipos del virus del dengue. - Google Patents
Nuevas vacunas contra multiples subtipos del virus del dengue.Info
- Publication number
- MX365656B MX365656B MX2015011485A MX2015011485A MX365656B MX 365656 B MX365656 B MX 365656B MX 2015011485 A MX2015011485 A MX 2015011485A MX 2015011485 A MX2015011485 A MX 2015011485A MX 365656 B MX365656 B MX 365656B
- Authority
- MX
- Mexico
- Prior art keywords
- mammal
- dengue
- dengue virus
- immune response
- dna plasmid
- Prior art date
Links
- 241000725619 Dengue virus Species 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 4
- 208000001490 Dengue Diseases 0.000 abstract 3
- 206010012310 Dengue fever Diseases 0.000 abstract 3
- 208000025729 dengue disease Diseases 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 3
- 239000013612 plasmid Substances 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
Abstract
La presente invención se refiere a constructos de ácido nucleico capaces de expresar un polipéptido, tal como un dengue de consenso prME que induce una respuesta inmune en un mamífero contra más de un subtipo del virus del dengue, y sus métodos de uso; en forma adicional, existen vacunas de plásmido de ADN capaces de generar en un mamífero una respuesta inmune contra una pluralidad de subtipos del virus del dengue, que comprenden un plásmido de ADN y un excipiente farmacéuticamente aceptable, y sus métodos de uso; el plásmido de ADN es capaz de expresar un antígeno del dengue de consenso en una célula del mamífero en una cantidad efectiva para inducir una respuesta inmune en el mamífero que es reactiva en forma cruzada contra los 4 subtipos de dengue.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361801972P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/029341 WO2014144786A1 (en) | 2013-03-15 | 2014-03-14 | Novel vaccines against multiple subtypes of dengue virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015011485A MX2015011485A (es) | 2016-09-23 |
| MX365656B true MX365656B (es) | 2019-06-10 |
Family
ID=54842920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015011485A MX365656B (es) | 2013-03-15 | 2014-03-14 | Nuevas vacunas contra multiples subtipos del virus del dengue. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2968394A4 (es) |
| JP (1) | JP6457481B2 (es) |
| KR (1) | KR20160004267A (es) |
| CN (2) | CN110055265A (es) |
| HK (1) | HK1219904A1 (es) |
| MX (1) | MX365656B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3515482A4 (en) * | 2016-09-19 | 2020-09-30 | The Wistar Institute Of Anatomy And Biology | ASSOCIATION OF NEW ZIKA VIRUS VACCINES AND ANTI-DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST ZIKA VIRUS |
| CN117164681B (zh) * | 2023-09-08 | 2025-07-25 | 中国人民解放军陆军军医大学 | 一种基于球形核酸载体的登革多肽疫苗及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101255419B1 (ko) * | 2007-11-12 | 2013-04-17 | 이노비오 파마수티컬즈, 인크. | 인플루엔자 바이러스의 다중 아형에 대한 신규 백신 |
| CN101909635B (zh) * | 2008-01-11 | 2014-09-17 | Vgx药品有限责任公司 | 针对多种登革病毒亚型的新颖疫苗 |
| CN101948850A (zh) * | 2010-08-13 | 2011-01-19 | 中国疾病预防控制中心病毒病预防控制所 | 登革病毒病毒样颗粒的制备方法及应用 |
| WO2012027473A2 (en) * | 2010-08-24 | 2012-03-01 | The University Of North Carolina At Chapel Hill | Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens |
| EP2621525A4 (en) * | 2010-10-01 | 2015-01-14 | Univ Rochester | Flavivirus DOMAIN III VACCINE |
| CN102363751A (zh) * | 2011-03-24 | 2012-02-29 | 中山大学 | 登革病毒样颗粒及其制备方法与应用 |
-
2014
- 2014-03-14 CN CN201910229555.6A patent/CN110055265A/zh active Pending
- 2014-03-14 HK HK16108101.1A patent/HK1219904A1/zh unknown
- 2014-03-14 CN CN201480013820.2A patent/CN105246491B/zh not_active Expired - Fee Related
- 2014-03-14 EP EP14763126.1A patent/EP2968394A4/en not_active Withdrawn
- 2014-03-14 JP JP2016503065A patent/JP6457481B2/ja not_active Expired - Fee Related
- 2014-03-14 KR KR1020157028919A patent/KR20160004267A/ko not_active Ceased
- 2014-03-14 MX MX2015011485A patent/MX365656B/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2968394A4 (en) | 2016-04-20 |
| JP6457481B2 (ja) | 2019-01-23 |
| CN110055265A (zh) | 2019-07-26 |
| JP2016515816A (ja) | 2016-06-02 |
| MX2015011485A (es) | 2016-09-23 |
| KR20160004267A (ko) | 2016-01-12 |
| CN105246491A (zh) | 2016-01-13 |
| HK1219904A1 (zh) | 2017-04-21 |
| CN105246491B (zh) | 2019-04-19 |
| EP2968394A1 (en) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023006203A (es) | Vacunas novedosas contra el virus de zika. | |
| MX2010007461A (es) | Nuevas vacunas contra multiples subtipos del virus del dengue. | |
| MX389568B (es) | Péptidos y uso de los mismos en inmunoterapia contra varios tumores, tales como cáncer de pulmón, que incluye cáncer de pulmón de células no pequeñas (nsclc) | |
| EA201591287A1 (ru) | Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения | |
| NZ616304A (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
| MX2016011686A (es) | Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc). | |
| MX2021006932A (es) | Receptores de celulas t humanas con alta afinidad modificados por medio de manipulacion genetica. | |
| PH12021551208A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| MX2013008836A (es) | Moleculas de acido nucleico que codifican novedosos antigenos de herpes, vacunas que las comprenden y metodos para su uso. | |
| IN2015DN02546A (es) | ||
| MX2017007138A (es) | Metodos y composiciones para terapia celular adoptiva. | |
| MX2020011673A (es) | Peptidos novedosos y acidos nucleicos de los mismos contra tumores tal como los de cancer gastrico y gastrointestinal. | |
| WO2011163628A3 (en) | Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof | |
| WO2016073595A8 (en) | T cells and dendritic cells for polyomavirus therapy | |
| EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
| MX2011007692A (es) | Vacunas mejoradas para el virus del papiloma humano y procedimientos para su utilizacion. | |
| WO2014004385A3 (en) | Anti-cancer vaccines | |
| MX2013013800A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
| WO2016168214A3 (en) | Immunogenic fusion proteins for the treatment of cancer | |
| EA033242B1 (ru) | Усовершенствованные нуклеиновые кислоты и белки вируса человеческой папилломы, вакцины и композиции на их основе и способы индукции иммунного ответа против впч с их применением | |
| CL2012003219A1 (es) | Parapoxvirus recombinante que comprende un parapoxvirus y adn heterólogo derivado de un virus de la rabia; procedimiento de preparación de dicho parapoxvirus; composicion inmunogénica; uso de la composicion para inducir respuesta inmunitaria contra el virus de la rabia en un animal. | |
| WO2015048796A3 (en) | Mosaic hiv envelope immunogenic polypeptides | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| MX2015011485A (es) | Nuevas vacunas contra multiples subtipos del virus del dengue. | |
| IN2014DN09445A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |